Intuitive Surgical (ISRG) reported earnings on Thur 21 Jul 22 (a/h)

 

Intuitive Surgical misses by $0.06, misses on revs; increases share repurchase authorization to $3.5 bln 

• Reports Q2 (Jun) earnings of $1.14 per share, excluding non-recurring items, $0.06 worse than the S&P Capital IQ Consensus of $1.20; revenues rose 4.0% year/year to $1.52 bln vs the $1.56 bln S&P Capital IQ Consensus.
• In July 2022, the Company's Board of Directors increased the authorized amount available under the Company's common stock repurchase program up to $3.5 billion.

Intuitive Surgical (ISRG) announces 3:1 split

Intuitive Surgical announces Board approval of 3:1 split; to begin trading split-adjusted on Oct. 5

Implementation of the stock split is subject to stockholder approval of the Amendment to the Certificate of Incorporation at the Special Meeting of Stockholders, which is currently scheduled to take place on September 20. Subject to stockholder approval of the Amendment to the Certificate of Incorporation, each Intuitive stockholder of record at the close of business on the record date of September 27, will receive two additional shares for every one share held on the record date, and trading is expected to begin on a split-adjusted basis on October 5.   ** 11 months later **

Intuitive Surgical (ISRG) reported earnings on Thur 18 Apr 19 (a/h)

** charts before earnings **

 

** charts after earnings **

Intuitive Surgical stock crashed late Thursday after the robotic surgery outlet reported lagging first-quarter sales and earnings that also decelerated.

Shares of Intuitive Surgical (ISRG) plummeted 6.2%, near 495, in after-hours trading on the stock market today. Intuitive Surgical stock ended the regular session 0.6% higher, at 528.06, during the regular session.

For the first quarter ended March 31, Intuitive Surgical earnings came in at $2.61 per share, on an adjusted basis. Intuitive Surgical earnings grew 7%, but decelerated from 20% growth in the fourth quarter. They also lagged the consensus of analysts polled by Zacks Investment Research for $2.70.

Revenue grew about 15% to $973.7 million, but that was also slower than 17% sales growth in the prior quarter. Analysts forecast $980 million in first-quarter sales.

Intuitive Surgical Earnings, Sales Fall Short
Procedure growth for Intuitive Surgical's robotic surgery system, da Vinci, remained in the double digits at 18%. The robotic surgery player also shipped 235 da Vinci systems, an increase of 27% vs. the year-earlier period.

"We are pleased with our first-quarter procedure and da Vinci system placements," Chief Executive Gary Guthart said in a written statement.

But the company didn't provide guidance for 2019. Analysts called for full-year Intuitive Surgical earnings of $11.99 per share on $4.31 billion in sales.

Intuitive Surgical (ISRG) reported earnings on Tue 17 Apr 18 (a/h)

** charts before earnings **

 

** charts after earnings **

 

Intuitive Surgical beats by $0.38, beats on revs 

• Reports Q1 (Mar) earnings of $2.44 per share, excluding non-recurring items, $0.38 better than the Capital IQ Consensus of $2.06; revenues rose 25.8% year/year to $848 mln vs the $773.2 mln Capital IQ Consensus.
• Worldwide da Vinci procedures grew approximately 15% compared with the first quarter of 2017, driven primarily by growth in U.S. general surgery procedures and worldwide urologic procedures (FY18 guidance is in the range of 11-15%).
• The Company shipped 185 da Vinci Surgical Systems compared with 133 in the first quarter of 2017.

=Intuitive Surgical (ISRG) raises Q4 guidance

Intuitive Surgical guides Q4 rev above consensus; sees da vinci procedures up 9-12% in 2016 after growing 14% in 2015 :

Company expects revenue for Q4 of ~$677 mln vs. the $649.2 mln consensus, an increase of ~12% YoY.

• Preliminary fourth quarter 2015 instrument and accessory revenue increased ~16% to ~$326 million compared with $281 million for the fourth quarter of 2014. Preliminary fourth quarter 2015 da Vinci Surgical Systems revenue increased ~8% to ~$231 million from $214 million for the fourth quarter of 2014. Preliminary fourth quarter 2015 service revenue of $120 million increased ~9% compared with $110 million in the fourth quarter of 2014.
• da Vinci procedures increased ~15% YoY in Q4.

The Company expects total da Vinci procedures to grow ~9% to 12% in 2016.